Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | BMY | VRTX | GILD |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 273.43 | 276.26 | 59.11 | 438.73 | 92.36 |
| High | 279.67 | 277.36 | 60.00 | 442.66 | 94.00 |
| Low | 271.52 | 273.50 | 59.10 | 436.61 | 92.26 |
| Last | 278.76 | 275.42 | 59.67 | 439.62 | 93.07 |
| Change | +3.22 | -2.46 | +0.53 | -0.11 | +0.15 |
| % Change | +1.17% | -0.89% | +0.90% | -0.03% | +0.16% |
| Volume | 924,100 | 2,008,700 | 12,677,500 | 1,647,800 | 5,409,400 |
| 20-Day Average Volume | 623,880 | 2,828,535 | 8,858,960 | 1,483,045 | 5,845,835 |
| Previous Close | 275.54 | 277.88 | 59.14 | 439.73 | 92.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 247.08 | 266.36 | 56.92 | 414.92 | 91.99 |
| 20-Day Raw Stochastic | 98.13% | 87.69% | 93.64% | 92.84% | 75.25% |
| 20-Day Relative Strength | 63.35% | 51.30% | 62.13% | 53.12% | 55.42% |
| Weighted Alpha | +33.59 | -13.44 | +27.88 | -1.02 | +24.91 |
| Today's Opinion | 40% Buy | 56% Sell | 88% Buy | 72% Sell | 96% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 80% Buy | 72% Sell | 96% Buy |
| Last Month's Opinion | 8% Sell | 88% Sell | 80% Buy | 72% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.88% since 01/16/25 | +2.22% since 01/16/25 | +5.84% since 01/16/25 | +5.43% since 01/16/25 | +1.55% since 01/16/25 |
| Low | 245.69 on 01/17/25 | 269.78 on 01/17/25 | 55.55 on 01/17/25 | 419.27 on 01/17/25 | 91.68 on 01/17/25 |
| High | 279.67 on 01/24/25 | 278.00 on 01/23/25 | 60.00 on 01/24/25 | 442.89 on 01/23/25 | 94.00 on 01/24/25 |
| 1-Month | |||||
| %Chg | +14.60% since 12/24/24 | +4.13% since 12/24/24 | +3.31% since 12/24/24 | +7.70% since 12/24/24 | -0.94% since 12/24/24 |
| Low | 231.00 on 01/06/25 | 257.05 on 01/06/25 | 54.81 on 01/13/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 |
| High | 279.67 on 01/24/25 | 278.00 on 01/23/25 | 60.00 on 01/24/25 | 442.89 on 01/23/25 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | -5.08% since 10/24/24 | -12.76% since 10/24/24 | +12.76% since 10/24/24 | -6.84% since 10/24/24 | +4.83% since 10/24/24 |
| Low | 229.85 on 11/18/24 | 253.30 on 12/19/24 | 51.81 on 10/28/24 | 377.85 on 12/19/24 | 86.08 on 11/19/24 |
| High | 293.74 on 10/25/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +17.88% since 07/24/24 | -17.93% since 07/24/24 | +33.61% since 07/24/24 | -10.43% since 07/24/24 | +26.63% since 07/24/24 |
| Low | 229.85 on 11/18/24 | 253.30 on 12/19/24 | 44.49 on 07/25/24 | 377.85 on 12/19/24 | 72.43 on 08/12/24 |
| High | 304.39 on 10/17/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 35,954,744 | 148,047,344 | 121,021,320 | 113,214,888 | 115,989,984 |
| Shares Outstanding, K | 128,981 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 500,920,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -111,570,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.34 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 02/20/25 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.46 | 50.55 | 0.00 | 20.98 |